The management of hypertension for an acute stroke: What is the blood pressure goal?

Current Cardiology Reports

Volumn 15, Issue 6, 2013, Pages

  Gorelick, Philip B ^a   Aiyagari, Venkatesh ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Acute stroke; Blood pressure; Guidelines; Hemorrhagic stroke; Hypertension; Ischemic stroke; Mean arterial pressure

Indexed keywords

CANDESARTAN; ENALAPRIL; ESMOLOL; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; LISINOPRIL; NICARDIPINE; NITROPRUSSIDE SODIUM; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR; ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; PATIENT CARE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SUBARACHNOID HEMORRHAGE; BLOOD PRESSURE MEASUREMENT; DRUG EFFECT; EVIDENCE BASED MEDICINE; FEMALE; INTRACRANIAL PRESSURE; MALE; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BRAIN ISCHEMIA; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINES AS TOPIC; HUMANS; HYPERTENSION; INTRACRANIAL HEMORRHAGES; INTRACRANIAL PRESSURE; MALE; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 84876193984     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0366-2     Document Type: Article

References (28)

1. Gorelick PB, Ruland S. Cerebral vascular disease. Disease-a-Month. 2010;56:33-100.
2. Testai FD, Gorelick PB. Potential for stroke prevention. In: Spence D, Barnett HJM, editors. Stroke prevention, treatment & rehabilitation. New York: McGraw Hill; 2012. p. 22-38.
3. Hypertension and Stroke. In: Aiyagari V, Gorelick PB, editors. New York: Humana; 2011. p. 3-279.
4. Goldstein LB. Blood pressure management in patients with acute ischemic stroke. Hypertension. 2004;43:137-41. (Pubitemid 38174162)
5. Owens WB. Blood pressure control in acute cerebrovascular disease. J Clin Hypertens. 2011;13:205-2011.
6. Symon L, Crockhard HA, Dorsch NW, Branston NM, Juhasz J. Local cerebral blood flow and vascular reactivity in chronic stable stroke in baboons. Stroke. 1975;6:482-92.
7. Jordan JD, Powers WJ. Cerebral autoregulation and acute ischemic stroke. Am J Hypertens. 2012;25:946-50.
8. Powers WJ, Videen TO, Diringer MN, Aiyagari V, Zazulia AR. Autoregulation after ischemic stroke. J Hypertens. 2009;27:2218-22.
9. Aiyagari V, Gorelick PB. Management of blood pressure for acute and recurrent stroke. Stroke. 2009;40:2251-6.
10. Zazulia AR, Diringer MN, Videen TO, Adams RE, Yundt K, Aiyagari V, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001;21:804-10. (Pubitemid 32613534)
11. Powers WJ, Zazulia AR, Videen TO, Adams RE, Yundt KD, Aiyagari V, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001;57:18-24. (Pubitemid 32634845)
12. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA. IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002;33:1315-20. (Pubitemid 34517053)
13. Menon RS, Burgess RE, Wing JJ, Gibbons MC, Shara NM, Fernandez S, et al. Predictors of highly prevalent brain ischemia in intracerebral hemorrhage. Ann Neurol. 2012;71:199-205.
14. Prabhakaran S, Naidech AM. Ischemic brain injury after intracerebral hemorrhage. A critical review. Stroke. 2012;43:2258-63.
15. •• Diringer MN, Bleck TP, Hemphill III CJ, Menon D, Shutter L, et al. Critical Care Management of Patients Following AneurysmalSubarachnoid Hemorrhage: Recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15:211-40. A guideline for critical care management of aneurysmal subarachnoid hemorrhage that includes recommendations for blood pressure control.
16. Sandset EC, Bath PMW, Boysen G, Jatuzis D, Korv J, Luders S, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomized, placebo-controlled double-blind trial. Lancet. 2011;377:741-50.
17. Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, et al. The ACCESS Study. Evaluation of acute candesartan cilixetil therapy in stroke survivors. Stroke. 2003;34:1699-703. (Pubitemid 36842630)
18. Robinson TG, Potter JF, Ford GA, Bulpitt C, Chernova J, Jagger C, et al. Effects of antihypertensive Collaborative Study (COSSACS): a prospective, randomized, open, blinded-endpoint trial. Lancet Neurol. 2010;9:767-75.
19. Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomized, placebo-controlled, double-blind pilot trial. Lancet Neurol. 2009;8:38-56.
20. • Gorelick PB. Is reduction of blood pressure in acute stroke justified? Lancet Neurol. 2011;10:295-6. An editorial comment about the pros and cons of blood pressure lowering in acute ischemic stroke and addresses the question of whether blood pressure lowering is justified.
21. Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al. Intensive blood pressure reduction in acute cerebral hemorrhage trial (INTERACT): a randomized, pilot trial. Lancet Neurol. 2008;7:391-9.
22. Delcourt C, Huang Y, Wang J, Heeley E, Lindley R, Stapf C, et al. The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). Int J Stroke. 2010;5:110-6.
23. Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011;15:559-76.
24. •• Morgenstern LB, Hemphill JC, Anderson C, Becker K, Broderick FP, Connolly ES, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108-29. A major American Heart Association guideline on brain hemorrhage that includes blood pressure lowering management recommendations.
25. •• Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711-33. A major American Heart Association guideline on aneurysmal subarachnoid hemorrhage that includes blood pressure lowering management recommendations.
26. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke. 2007;38:1655-711. (Pubitemid 46691097)
27. •• Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870-947. doi: 10.1161/STR.0b013e318284056a. A major American Heart Association guideline for acute ischemic stroke that includes blood pressure lowering management recommendations.
28. Kang J, Ko Y, Park JH, Kim W-J, Jang MS, Yang MH, et al. Effect of blood pressure on 3-month functional outcome in the subacute stage of ischemic stroke. Neurology. 2012;79:2018-24.